-transparent.png){kind=logo}
1. KRN4884 is a novel pyridinecarboxamidine type potassium channel opener. 2. To determine whether KRN4884 affects lipid metabolism, we investigated its effects on serum lipid levels by using two types of hyperlipidemic rats: genetically hyperlipidemic obese Zucker rats and diet-induced hyperlipidemic rats fed a high fat diet. KRN4884 dose dependently decreased systolic blood pressure in Zucker rats. 3. Oral administration of KRN4884 (1-10 mg/(kg day) for 14 days dose dependently reduced serum triglyceride levels in Zucker rats. The reductions in serum triglyceride were associated with reductions in triglyceride in chylomicron and very low density lipoprotein. 4. KRN4884 produced no change in serum insulin and glucose levels in Zucker rats. 5. KRN4884 exhibited a similar triglyceride lowering effect in diet-induced hyperlipidemic rats. 6. These results suggest that KRN4884 has a beneficial effect on serum triglyceride levels as well as a hypotensive effect.
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
January 2007,
Asia Pacific journal of clinical nutrition,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
July 2011,
Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
February 2015,
Experimental gerontology,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
July 1972,
The Journal of clinical investigation,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
June 1983,
Journal of pharmacobio-dynamics,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
January 2014,
TheScientificWorldJournal,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
January 1979,
General pharmacology,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
January 2014,
African journal of traditional, complementary, and alternative medicines : AJTCAM,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
April 2019,
Food science and biotechnology,
T Yokoyama, and
H Izumi, and
M Endoh, and
N Ogawa, and
T Izawa, and
Y Okada
January 2020,
Frontiers in pharmacology,
